Antihistamines
Also discussed as: antihistamines, antihistamine, anti-histamines, oral antihistamine, oral antihistamines, antihistamine use
PROMISING
2 level-I · 14 level-II · 4 level-IV · 4 level-VI · 11 level-III · 4 level-VII
Research base (design-resolved): 2 systematic review/meta-analysis, 14 randomized trials, 19 observational/descriptive.
very high · 22,597 mentions
Most discussed for: oral_medication, topical_otc, other
What the research says
Resulted in a significant reduction in E-MDA levels after 2 months of treatment. (n=16336)
Cordiano et al. (2023), Molecules. doi:10.3390/molecules28165979 · verifiedThe use of antihistamines is recommended to relieve pruritus and prevent exacerbation due to scratching in AD patients.
Kim et al. (2015), Annals of Dermatology. doi:10.5021/ad.2015.27.5.578 · verifiedKetotifen significantly lowered AA risk in infants with AD or other pre-asthmatic conditions.
Yang et al. (2020), Frontiers in Immunology. doi:10.3389/fimmu.2020.01907 · verifiedAntihistamines have been reported to have beneficial effects on reducing itch in 75% of randomized clinical trials.
Katoh et al. (2020), Allergology International. doi:10.1016/j.alit.2020.02.006 · verifiedAntihistamines or mast cell stabilizers were used to manage conjunctivitis in dupilumab trials. (n=1047)
Akinlade et al. (2019), British Journal of Dermatology. doi:10.1111/bjd.17869 · verifiedH1-antihistamines are a standard treatment for mast cell-mediated allergic diseases.
Thangam et al. (2018), Frontiers in Immunology. doi:10.3389/fimmu.2018.01873 · verifiedSubjects treated with ketotifen had a significantly lower frequency of asthma at follow-up than control subjects.
Han et al. (2017), Immunological Reviews. doi:10.1111/imr.12546 · verifiedWhat the community reports
Experience reports, not evidence. Volumes from 1.1M triaged posts.
- oral_medication
- topical_otc
- other
- topical_prescription
- lifestyle_change
- supplement
Safety and side effects
Common side effects include sedation and drowsiness, which may affect some individuals.
For infants and children
Antihistamines should be used with caution in children, but they are approved for infants aged 6 months and older.
Studied protocols
As reported in the papers, not recommendations.
dose: 50 mg/kg; frequency: once; route: intraperitoneal
Wang et al. (2021), Journal of Translational Medicinedose: 10 mg/kg; frequency: oral administration; route: oral; duration: 5 weeks
Kang et al. (2020), Scientific Reportsdose: 0.5 mg/kg; frequency: daily; route: oral; duration: 7 days
Woo et al. (2021), Nutrientsroute: oral
Selene K. Bantz (2014), Journal of Clinical & Cellular Immunologyroute: topical
Akinlade et al. (2019), British Journal of Dermatologydose: 1 mg/kg
Kwon et al. (2018), Frontiers in ImmunologyDrawn from 33 papers · generated 2026-06-11T12:40:56.184720+00:00 · phrasing by gpt-4o-mini, every number computed from the database and every citation machine-verified.